(A–F) Uniform Manifold Approximation and Projection (UMAP) dimensionality reduction of all monocytes and macrophages in single-cell RNA-sequencing (scRNA-seq) of liver (A), lung (B), heart (C), skin …
Marker genes for monocyte / macrophages.
Marker genes for TREM2+ macrophages.
GSEA analysis of DEG between SPP1+ macrophages and other macrophages in each tissue.
(A) Scatterplot of Silhouette score (see Materials and methods) of single-cell unsupervised Louvain clustering results at different resolutions, which dictates the granularity of clustering. The …
(A) Scatterplot of Silhouette score (see Materials and methods) of single-cell unsupervised Louvain clustering results at different resolutions, which dictates the granularity of clustering. The …
(A) Scatterplot of Silhouette score (see Materials and methods) of single-cell unsupervised Louvain clustering results at different resolutions, which dictates the granularity of clustering. The …
(A) Scatterplot of Silhouette score (see Materials and methods) of single-cell unsupervised Louvain clustering results at different resolutions, which dictates the granularity of clustering. The …
(A) Scatterplot of Silhouette score (see Materials and methods) of single-cell unsupervised Louvain clustering results at different resolutions, which dictates the granularity of clustering. The …
(A) Scatterplot of Silhouette score (see Materials and methods) of single-cell unsupervised Louvain clustering results at different resolutions, which dictates the granularity of clustering. The …
(A) Uniform Manifold Approximation and Projection (UMAP) dimensionality reduction of all SPP1+ macrophages merged from the liver, lung, heart, skin, endometrium, and kidney tissues following data …
Marker genes for subclusters within SPP1+ macrophages.
Signature genes of SPP1+MAM+ macrophages.
GSEA analysis of pathways upregulated/downregulated in SPP1+MAM+ macrophages (relative to SPP1+MAM- macrophages).
Signature genes of "ECM-remodeling processes" upregulated in SPP1+MAM+ macrophages.
Signature genes of "metabolic processes" upregulated in SPP1+MAM+ macrophages.
(A) Uniform Manifold Approximation and Projection (UMAP) projection of SPP1+ macrophages, coloured by their tissue of origin. (B) Scatterplot of Silhouette score (see Materials and methods) of …
Scatterplot ranks the number of occurrences of a gene in a four-marker panel of SPP1+MAM+ macrophages, as predicted by COMET (see Materials and methods). The Elbow method (dashed lines) was employed …
(A) t-SNE of immune cells isolated from the temporal lobe epilepsy patients (Kumar et al., 2022b; in the manuscript; n=4 patients). Microglial cells as defined in the original paper are coloured in …
(A) Uniform Manifold Approximation and Projection (UMAP) of human liver macrophages coloured by a SAM signature score defined using the genes SPP1, TREM2, and CD9. (B) Applying a z-score cutoff of …
(A–F) Slingshot differentiation trajectory analyses of macrophages in the liver (A), lung (B), heart (C), skin (D), endometrium (E), and kidney (F). The predicted trajectories are drawn on Uniform …
Monocle differentiation trajectory analyses in the liver, lung, heart, skin, endometrium, and kidney (see Table 1 for information regarding the origin of human tissues and the number of sequenced …
(A) Rank plot for the 173 regulons active in SPP1+MAM+ macrophages, ordered by the diagnostic odd ratio (DOR) (y-axis), which calculates the odds of the regulon being activated in SPP1+MAM+ cells …
Member genes of regulons listed in Figure 4D.
(A) Scatterplot evaluating the pseudo-bulk expression of the homeostatic RNASE1+, SPP1+MAM-, SPP1+MAM+, SPP1+MAM+ extracellular matrix (ECM) remodelling, and SPP1+MAM+ metabolic processes signatures …
Signature genes of SPP1+MAM- macrophages.
Homeostatic signature regression model.
SPP1+MAM- signature regression model.
SPP1+MAM+ signature regression model.
SPP1+MAM+ ECM signature regression model.
SPP1+MAM+ Metabolic signature regression model.
The homeostatic RNASE1+ signature, pseudo-bulk at the donor level, is further stratified according to the donor’s smoking status and linear regression is performed separately on each of the donor …
For each study, the sample size (number of single-cell datasets), age/gender, disease status, the number (and percentage) of tissue resident macrophages (Mφ), and the total number of live cells …
Tissue | Study(ref in article) | Repository | Disease status | Sample size (n) | Sex (%M) | Age (years)± SD | TissueMφ (%) | Total cells (#) |
---|---|---|---|---|---|---|---|---|
Liver | Ramachandran et al., 2019 | GSE136103 | Cirrhosis | 5 | 80.0 | 56.6±5.8 | 8332 (13.9%) | 60,094 CD45+ cells1 |
Normal | 5 | 60.0 | 57.4±7.9 | |||||
Liver | Fred et al., 2022 | Author provided data | NASH | 10 | 50.0 | 47.0±7.5 | 2069 (12.1%) | 17,154 |
Lung | Morse et al., 2019 | GSE128033 | IPF | 3 | 33.3 | 69.3±0.6 | 17,570 (39.3%) | 44,652 |
Normal | 4 | 50.0 | 38.3±20.6 | |||||
Lung | Reyfman et al., 2019 | GSE122960 | IPF | 4 | 75 | 66.5±5.0 | 32,136 (41.7%) | 77,079 |
Normal | 8 | 25 | 42.9±15.5 | |||||
SSC | 2 | 0 | 46.0±9.9 | |||||
Lung | Adams et al., 2020 | GSE136831 | IPF | 32 | 81.3 | 65.4±5.4 | 117,184 (37.4%) | 312,928 |
Normal | 17 | 58.8 | 44.4±18.9 | |||||
Lung | Valenzi et al., 2019 | GSE128169 GSE156310 | IPF | 1 | 100.0 | 68.0 | 17,407 (44.3%) | 39,252 |
SSC | 4 | 75.0 | 56.8±9.5 | |||||
Heart | Koenig et al., 2022 | GSE183852 | DCM | 5 | 60.0 | 50.0±19.2 | 3,922 (7.9%) | 49,665 |
Normal | 2 | 100.0 | 50.5±17.7 | |||||
Heart | Rao et al., 2021 | GSE145154 | DCM | 2 | 100.0 | 61.0±1.4 | 20,539 (30.0%) | 68,516 CD45+ cells |
ICM | 4 | 100.0 | 47.3±10.6 | |||||
Normal | 1 | 100.0 | 53.0 | |||||
Skin2 | Gur et al., 2022 | GSE195452 | Normal | 22 | 22.7 | 44.8±10.4 | 2456 (15.6%) | 15,700 CD45+ cells |
SSC | 55 | 5.4 | 50.1±13.2 | |||||
Skin | Deng et al., 2021 | GSE163973 | Keloid | 3 | 66.7 | 25.6±7.3 | 320 (0.7%) | 45,094 |
Normal | 3 | 66.7 | 31.0±7.0 | |||||
Endo- metrium | Tan et al., 2022 | GSE179640 | Endometriosis | 9 | 0.0 | 35.8±5.8 | 3079 (8.6%) | 35,941 |
Normal | 3 | 0.0 | 33.3±10.3 | |||||
Endo- metrium | Fonseca et al., 2023 | GSE213216 | Endometriosis | 22 | 0.0 | 34.1±7.6 | 2951 (1.8%) | 163,882 |
Normal | 8 | 0.0 | 37.9±10.1 | |||||
Kidney | Kuppe et al., 2021 | Zenodo 4059315 | CKD | 6 | 66.7 | 70.8±12.5 | 3596 (7.5%) | 48,096 CD10- cells |
Normal | 4 | 100.0 | 65.3±11.3 | |||||
Kidney | Lake et al., 2023 | atlas.kpmp.org | AKI | 11 | 72.7 | 50.2±19.1 | 1597 (3.5%) | 46,249 |
CKD | 15 | 66.7 | 61.9±12.7 | |||||
Normal | 14 | 50.0 | 45.9±10.3 | |||||
Kidney | Malone et al., 2020 | GSE145927 | AKI | 3 | 100.0 | 49.3±18.2 | 2772 (4.6%) | 60,080 |
Normal | 2 | 50.0 | 54.0±1.0 |